Search research articles
Contact Us
Filters
Showing results (41-50 of 101) with videos related to
Page
of 11
Sort By:
Hematology/Oncology and Stem Cell Therapy
|
May 31, 2020
Allogeneic hematopoietic cell transplantation is an effective treatment for patients with Richter syndrome: A systematic review and meta-analysis
Sonikpreet Aulakh, Tea Reljic, Farah Yassine, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 21, 2018
A Phase I Study to Assess the Safety and Pharmacokinetics of Single-agent Lorvotuzumab Mertansine (IMGN901) in Patients with Relapsed and/or Refractory CD-56-positive Multiple Myeloma
Sikander Ailawadhi, Kevin R Kelly, Robert A Vescio, et al.
Leukemia Research
|
September 12, 2006
Regular analgesic use and risk of multiple myeloma
Kirsten B Moysich, Mathew R Bonner, Gregory P Beehler, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 23, 2015
Persistent Disparities Among Patients With T-Cell Non-Hodgkin Lymphomas and B-Cell Diffuse Large Cell Lymphomas Over 40 Years: A SEER Database Review
Jennifer A Crozier, Taimur Sher, Dongyun Yang, et al.
Cancer
|
April 28, 2011
Tumor flare reaction associated with lenalidomide treatment in patients with chronic lymphocytic leukemia predicts clinical response
Asher Chanan-Khan, Kena C Miller, David Lawrence, et al.
Cancers
|
November 27, 2021
Landmark Cancer Clinical Trials and Real-World Patient Populations: Examining Race and Age Reporting
Thejus Jayakrishnan, Sonikpreet Aulakh, Mizba Baksh, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 24, 2021
Trends in Early Mortality From Multiple Myeloma: A Population-Based Analysis
Vivek Kumar, Meghna Ailawadhi, Navnita Dutta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 6, 2006
The combination of the proteasome inhibitor bortezomib and the bcl-2 antisense molecule oblimersen sensitizes human B-cell lymphomas to cyclophosphamide
Owen A O'Connor, Emily A Smith, Lorraine E Toner, et al.
British Journal of Haematology
|
December 17, 2011
Downregulation of BCL2 by AT-101 enhances the antileukaemic effect of lenalidomide both by an immune dependant and independent manner
Aisha Masood, Kasyapa Chitta, Aneel Paulus, et al.
Blood
|
July 30, 2005
Results of a phase 1 clinical trial of thalidomide in combination with fludarabine as initial therapy for patients with treatment-requiring chronic lymphocytic leukemia (CLL)
Asher Chanan-Khan, Kena C Miller, Kenichi Takeshita, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 101) with videos related to
Sort By:
Page
of 11
Hematology/Oncology and Stem Cell Therapy
|
May 31, 2020
Allogeneic hematopoietic cell transplantation is an effective treatment for patients with Richter syndrome: A systematic review and meta-analysis
Sonikpreet Aulakh, Tea Reljic, Farah Yassine, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 21, 2018
A Phase I Study to Assess the Safety and Pharmacokinetics of Single-agent Lorvotuzumab Mertansine (IMGN901) in Patients with Relapsed and/or Refractory CD-56-positive Multiple Myeloma
Sikander Ailawadhi, Kevin R Kelly, Robert A Vescio, et al.
Leukemia Research
|
September 12, 2006
Regular analgesic use and risk of multiple myeloma
Kirsten B Moysich, Mathew R Bonner, Gregory P Beehler, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 23, 2015
Persistent Disparities Among Patients With T-Cell Non-Hodgkin Lymphomas and B-Cell Diffuse Large Cell Lymphomas Over 40 Years: A SEER Database Review
Jennifer A Crozier, Taimur Sher, Dongyun Yang, et al.
Cancer
|
April 28, 2011
Tumor flare reaction associated with lenalidomide treatment in patients with chronic lymphocytic leukemia predicts clinical response
Asher Chanan-Khan, Kena C Miller, David Lawrence, et al.
Cancers
|
November 27, 2021
Landmark Cancer Clinical Trials and Real-World Patient Populations: Examining Race and Age Reporting
Thejus Jayakrishnan, Sonikpreet Aulakh, Mizba Baksh, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 24, 2021
Trends in Early Mortality From Multiple Myeloma: A Population-Based Analysis
Vivek Kumar, Meghna Ailawadhi, Navnita Dutta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 6, 2006
The combination of the proteasome inhibitor bortezomib and the bcl-2 antisense molecule oblimersen sensitizes human B-cell lymphomas to cyclophosphamide
Owen A O'Connor, Emily A Smith, Lorraine E Toner, et al.
British Journal of Haematology
|
December 17, 2011
Downregulation of BCL2 by AT-101 enhances the antileukaemic effect of lenalidomide both by an immune dependant and independent manner
Aisha Masood, Kasyapa Chitta, Aneel Paulus, et al.
Blood
|
July 30, 2005
Results of a phase 1 clinical trial of thalidomide in combination with fludarabine as initial therapy for patients with treatment-requiring chronic lymphocytic leukemia (CLL)
Asher Chanan-Khan, Kena C Miller, Kenichi Takeshita, et al.
Page
of 11